MedDataX Logo

Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.

NCT ID: NCT06994208

Last Updated: 2025-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-02

Study Completion Date

2028-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of the study is to analyse a local cohort of patients aged 18-39 years with melanoma diagnosis in order to determine the prevalence of the disease in this age group.

Secondary objectives are the following:

* To identify risk factors associated with melanoma in young people.
* To characterise the phenotype and dermoscopic features of melanoma in patients aged 18-39 years.
* To analyse the relationship between the clinical and histopathological features of melanoma in young people.
* To identify the mutational status of B-RAF in the sample of patients analysed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Melanoma of Skin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ARM 1

Patients with melanoma diagnosis aged between 18 and 39 years.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. written informed consent
2. age \> 18 years and \< 40 years
3. diagnosis of cutaneous melanoma even non-primary

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Maximum Eligible Age

39 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ente Ospedaliero Ospedali Galliera

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sanja Javor

Medical doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sanja Javor

Role: PRINCIPAL_INVESTIGATOR

Ente Ospedaliero Ospedali Galliera

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

E.O. Ospedali Galliera

Genoa, Liguria, Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sanja Javor, MD

Role: CONTACT

Phone: +390105634271

Email: [email protected]

Davide Corradengo

Role: CONTACT

Phone: +39010.563.4580

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sanja Javor, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Melanoma_2025

Identifier Type: -

Identifier Source: org_study_id